Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Thomas Burke
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Geographic Areas
Chemicals & Drugs
Occupations
Disorders
Concepts & Ideas
Activities & Behaviors
Sign-in to see full Profile
Network (preview)
9
RESNICK, BETH
9
Goldstein, Jay
7
Zhao, Sean
6
Tran, Nga
5
Carides, George
4
von Allmen, Heather
4
Wentworth, Chuck
4
Sturkenboom, Miriam
4
Henderson, Scott
4
FOX, MARY
4
Litt, Jill
4
Whelton, Andrew
3
Zabinski, RA
3
Uscher Pines, Lori
3
Geis, Steven
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Thomas Burke (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2010: Abt Eileen; Rodricks Joseph V; Levy Jonathan I; Zeise Lauren; Burke Thomas A
Science and decisions: advancing risk assessment.
Risk analysis : an official publication of the Society for Risk Analysis 2010;30(7):1028-36.
-
2010: Fox Mary; Curriero Frank; Kulbicki Kathryn; Resnick Beth; Burke Thomas
Evaluating the community health legacy of WWI chemical weapons testing.
Journal of community health 2010;35(1):93-103.
-
2009: Resnick Beth A; Zablotsky Joanna; Burke Thomas A
Protecting and promoting the nation's health: the environmental public health workforce as a critical component.
Journal of public health management and practice : JPHMP 2009;15(6 Suppl):S40-5.
-
2009: Resnick Beth A; Zablotsky Joanna; Janus Erik R; Maggy Bradley; Burke Thomas A
An examination of environmental public health organizational and workforce configurations in the Northeast/Mid-Atlantic United States: how do we determine if these configurations impact performance?
Journal of public health management and practice : JPHMP 2009;15(6):509-17.
-
2009: Uscher-Pines Lori; Vernick Jon S; Curriero Frank; Lieberman Richard; Burke Thomas A
Disaster-related injuries in the period of recovery: the effect of prolonged displacement on risk of injury in older adults.
The Journal of trauma 2009;67(4):834-40.
-
2009: Rutkow Lainie; Levin Mindi B; Burke Thomas A
Meeting local needs while developing public health practice skills: a model community-academic partnership.
Journal of public health management and practice : JPHMP 2009;15(5):425-31.
-
2009: White Ronald H; Cote Ila; Zeise Lauren; Fox Mary; Dominici Francesca; Burke Thomas A; White Paul D; Hattis Dale B; Samet Jonathan M
State-of-the-science workshop report: issues and approaches in low-dose-response extrapolation for environmental health risk assessment.
Environmental health perspectives 2009;117(2):283-7.
-
2009: Chandwani Sheenu; Wentworth Chuck; Burke Thomas A; Patterson Thomas F
Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice.
Current medical research and opinion 2009;25(2):385-93.
-
2008: Malecki Kristen C; Resnick Beth; Burke Thomas A
Effective environmental public health surveillance programs: a framework for identifying and evaluating data resources and indicators.
Journal of public health management and practice : JPHMP 2008;14(6):543-51.
-
2008: Rodes Charles E; Pellizzari Edo D; Dellarco Michael J; Erickson Mitchell D; Vallero Daniel A; Reissman Dori B; Lioy Paul J; Lippmann Morton; Burke Thomas A; Goldstein Bernard D
ISEA2007 panel: integration of better exposure characterizations into disaster preparedness for responders and the public.
Journal of exposure science & environmental epidemiology 2008;18(6):541-50.
-
2008: Neff Roni A; Curriero Frank C; Burke Thomas A
Just in the wrong place...?: geographic tools for occupational injury/illness surveillance.
American journal of industrial medicine 2008;51(9):680-90.
-
2008: Phatak Hemant; Wentworth Chuck; Burke Thomas A
Lipid testing among patients beginning statin therapy in general practice in the United Kingdom.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2008;11(5):933-8.
-
2008: Kamal-Bahl Sachin J; Burke Thomas A; Watson Douglas J; Wentworth Charles E
Dosage, titration, and gaps in treatment with extended release niacin in clinical practice.
Current medical research and opinion 2008;24(6):1817-21.
-
2008: Nachman Keeve E; Mihalic Jana N; Burke Thomas A; Geyh Alison S
Comparison of arsenic content in pelletized poultry house waste and biosolids fertilizer.
Chemosphere 2008;71(3):500-6.
-
2008: Resnick Beth; Zablotsky Joanna; Nachman Keeve; Burke Thomas
Examining the front lines of local environmental public health practice: a Maryland case study.
Journal of public health management and practice : JPHMP 2008;14(1):42-50.
-
2007: Dreyling Erin; Dederick Elizabeth J; Chari Ramya; Resnick Beth; Malecki Kristen Chossek; Burke Thomas; Neff Roni
Tracking health and the environment: a pilot test of environmental public health indicators.
Journal of environmental health 2007;70(5):9-16, 38, 40; quiz 41-2.
-
2007: Burke Thomas A; Sturkenboom Miriam C; Ohman-Strickland Pamela A; Wentworth Charles E; Rhoads George G
The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
Pharmacoepidemiology and drug safety 2007;16(9):979-87.
-
2007: Van Ganse Eric; Laforest Laurent; Burke Thomas; Phatak Hemant; Souchet Thierry
Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Clinical therapeutics 2007;29(8):1671-81.
-
2007: Resnick Beth; Zablotsky Joanna; Farrow Olivia; Glotfelty Rodney; Heard Philip; Kelly Susan; Mitchell Clifford; Phillips Frances; Burke Thomas
Enhancing the Maryland environmental public health workforce: a collaborative approach.
Journal of environmental health 2007;70(1):32-6, 63.
-
2007: Ryan P Barry; Burke Thomas A; Cohen Hubal Elaine A; Cura Jerome J; McKone Thomas E
Using biomarkers to inform cumulative risk assessment.
Environmental health perspectives 2007;115(5):833-40.
-
2007: Juzych Nadia Shalauta; Resnick Beth; Streeter Robin; Herbstman Julie; Zablotsky Joanna; Fox Mary; Burke Thomas A
Adequacy of state capacity to address noncommunicable disease clusters in the era of environmental public health tracking.
American journal of public health 2007;97 Suppl 1():S163-9.
-
2007: Litt Jill S; Wismann Andrea; Resnick Beth; Dawson Rebecca Smullin; Hano Mary; Burke Thomas A
Advancing health and environmental disease tracking: a 5-year follow-up study.
American journal of public health 2007;97(3):456-63.
-
2007: Kamal-Bahl Sachin J; Burke Thomas; Watson Douglas; Wentworth Chuck
Discontinuation of lipid modifying drugs among commercially insured United States patients in recent clinical practice.
The American journal of cardiology 2007;99(4):530-4.
-
2007: Uscher-Pines Lori; Bookbinder Sylvia H; Miro Suzanne; Burke Thomas
From bioterrorism exercise to real-life public health crisis: lessons for emergency hotline operations.
Journal of public health management and practice : JPHMP 2007;13(1):16-22.
-
2006: Erazo Valle Aura; Wisniewski Tami; Figueroa Vadillo Jasmin Isabel; Burke Thomas A; Martinez Corona Roberto
Incidence of chemotherapy-induced nausea and vomiting in Mexico: healthcare provider predictions versus observed.
Current medical research and opinion 2006;22(12):2403-10.
-
2006: Burke Thomas A; Venketasubramanian Ramani N
The epidemiology of stroke in the East Asian region: a literature-based review.
International journal of stroke : official journal of the International Stroke Society 2006;1(4):208-15.
-
2006: Uscher-Pines Lori; Omer Saad B; Barnett Daniel J; Burke Thomas A; Balicer Ran D
Priority setting for pandemic influenza: an analysis of national preparedness plans.
PLoS medicine 2006;3(10):e436.
-
2006: Angerer Jürgen; Bird Michael G; Burke Thomas A; Doerrer Nancy G; Needham Larry; Robison Steven H; Sheldon Linda; Zenick Hal
Strategic biomonitoring initiatives: moving the science forward.
Toxicological sciences : an official journal of the Society of Toxicology 2006;93(1):3-10.
-
2006: Burke Thomas A; Sturkenboom Miriam C; Lu Shou-en; Wentworth Charles E; Lin Yong; Rhoads George G
Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice.
Journal of hypertension 2006;24(6):1193-200.
-
2006: Navas-Acien Ana; Silbergeld Ellen K; Streeter Robin A; Clark Jeanne M; Burke Thomas A; Guallar Eliseo
Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence.
Environmental health perspectives 2006;114(5):641-8.
-
2006: McInnes G; Burke T A; Carides G
Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study.
Journal of human hypertension 2006;20(1):51-8.
-
2005: Navas-Acien Ana; Sharrett A Richey; Silbergeld Ellen K; Schwartz Brian S; Nachman Keeve E; Burke Thomas A; Guallar Eliseo
Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence.
American journal of epidemiology 2005;162(11):1037-49.
-
2005: Seng Wong Kok; Hwang Shang-Jyh; Han Dong Cheol; Teong Chua Chin; Chan Juliana; Burke Thomas A; Carides George W; Choi Yon Jong
Losartan reduces the costs of diabetic end-stage renal disease: an Asian perspective.
Nephrology (Carlton, Vic.) 2005;10(5):520-4.
-
2005: Jönsson Bengt; Carides George W; Burke Thomas A; Dasbach Erik J; Lindholm Lars H; Dahlöf Björn;
Cost effectiveness of losartan in patients with hypertension and LVH: an economic evaluation for Sweden of the LIFE trial.
Journal of hypertension 2005;23(7):1425-31.
-
2005: Arredondo Armando; Burke Thomas A; Carides George W; Lemus Edith; Querol Julio
The impact of losartan on the lifetime incidence of ESRD and costs in Mexico.
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición 2005;57(3):399-405.
-
2004: Fox Mary A; Tran Nga L; Groopman John D; Burke Thomas A
Toxicological resources for cumulative risk: an example with hazardous air pollutants.
Regulatory toxicology and pharmacology : RTP 2004;40(3):305-11.
-
2004: Vicente-Herrero Teofila; Burke Thomas A; Laínez Miguel J A
The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
Current medical research and opinion 2004;20(11):1805-14.
-
2004: Litt Jill; Tran Nga; Malecki Kristen Chossek; Neff Roni; Resnick Beth; Burke Thomas
Identifying priority health conditions, environmental data, and infrastructure needs: a synopsis of the Pew Environmental Health tracking project.
Environmental health perspectives 2004;112(14):1414-8.
-
2004: Dueland Aud Nome; Leira Rogelio; Burke Thomas A; Hillyer Elizabeth V; Bolge Susan
The impact of migraine on work, family, and leisure among young women -- a multinational study.
Current medical research and opinion 2004;20(10):1595-604.
-
2004: Morant S V; Pettitt D; MacDonald T M; Burke T A; Goldstein J L
Application of a propensity score to adjust for channelling bias with NSAIDs.
Pharmacoepidemiology and drug safety 2004;13(6):345-53.
-
2004: Dahlöf B; Burke T A; Krobot K; Carides G W; Edelman J M; Devereux R B; Diener H-C
Population impact of losartan use on stroke in the European Union (EU): projections from the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Journal of human hypertension 2004;18(6):367-73.
-
2004: Zhao Sean Z; Wentworth Chuck; Burke Thomas A; Makuch Robert W
Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
Pharmacoepidemiology and drug safety 2004;13(5):277-87.
-
2004: Payne-Sturges Devon C; Burke Thomas A; Breysse Patrick; Diener-West Marie; Buckley Timothy J
Personal exposure meets risk assessment: a comparison of measured and modeled exposures and risks in an urban community.
Environmental health perspectives 2004;112(5):589-98.
-
2004: Tran Nga L; Barraj Leila; Smith Kim; Javier Annabelle; Burke Thomas A
Combining food frequency and survey data to quantify long-term dietary exposure: a methyl mercury case study.
Risk analysis : an official publication of the Society for Risk Analysis 2004;24(1):19-30.
-
2004: Wolfe Frederick; Michaud Kaleb; Burke Thomas A; Zhao Sean Z
Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
The Journal of rheumatology 2004;31(2):355-8.
-
2004: Stern Alan H; Jacobson Joseph L; Ryan Louise; Burke Thomas A
Do recent data from the Seychelles Islands alter the conclusions of the NRC Report on the toxicological effects of methylmercury?
Environmental health : a global access science source 2004;3(1):2.
-
2003: Goldstein Jay L; Zhao Sean Z; Burke Thomas A; Palmer Ryan; von Allmen Heather; Henderson Scott C
Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
The American journal of gastroenterology 2003;98(12):2627-34.
-
2003: Sturkenboom M C J M; Burke T A; Tangelder M J D; Dieleman J P; Walton S; Goldstein J L
Adherence to proton pump inhibitors or H2-receptor antagonists during the use of non-steroidal anti-inflammatory drugs.
Alimentary pharmacology & therapeutics 2003;18(11-12):1137-47.
-
2003: Sturkenboom M C J M; Burke T A; Dieleman J P; Tangelder M J D; Lee F; Goldstein J L
Underutilization of preventive strategies in patients receiving NSAIDs.
Rheumatology (Oxford, England) 2003;42 Suppl 3():iii23-31.
-
2003: MacDonald T M; Morant S V; Goldstein J L; Burke T A; Pettitt D
Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs.
Gut 2003;52(9):1265-70.
-
2003: Becker Russell V; Burke Thomas A; McCoy Mark A; Trotter Jeffrey P
A model analysis of costs of blood pressure destabilization and edema associated with rofecoxib and celecoxib among older patients with osteoarthritis and hypertension in a Medicare Choice population.
Clinical therapeutics 2003;25(2):647-62.
-
2002: Litt Jill S; Burke Thomas A
Uncovering the historic environmental hazards of urban brownfields.
Journal of urban health : bulletin of the New York Academy of Medicine 2002;79(4):464-81.
-
2002: Zhao Sean Z; Burke Thomas A; Whelton Andrew; von Allmen Heather; Henderson Scott C
Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
The American journal of managed care 2002;8(15 Suppl):S414-27.
-
2002: Zhao Sean Z; Burke Thomas A; Whelton Andrew; von Allmen Heather; Henderson Scott C
Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
The American journal of managed care 2002;8(15 Suppl):S401-13.
-
2002: Zhao Sean Z; Burke Thomas A; Whelton Andrew; von Allmen Heather; Henderson Scott C
Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
The American journal of managed care 2002;8(15 Suppl):S392-400.
-
2002: Osterhaus Jane T; Burke Thomas A; May Corey; Wentworth Chuck; Whelton Andrew; Bristol Susan
Physician-reported management of edema and destabilized blood pressure in cyclooxygenase-2-specific inhibitor users with osteoarthritis and treated hypertension.
Clinical therapeutics 2002;24(6):969-89.
-
2002: Wolfe Frederick; Flowers Nancy; Burke Thomas A; Arguelles Lester M; Pettitt Dan
Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis.
The Journal of rheumatology 2002;29(5):1015-22.
-
2002: Litt Jill S; Tran Nga L; Burke Thomas A
Examining urban brownfields through the public health "macroscope".
Environmental health perspectives 2002;110 Suppl 2():183-93.
-
2002: Goldstein J L; Eisen G M; Burke T A; Peña B M; Lefkowith J; Geis G S
Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac.
Alimentary pharmacology & therapeutics 2002;16(4):819-27.
-
2002: Wolfe Frederick; Anderson Janice; Burke Thomas A; Arguelles Lester M; Pettitt Dan
Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
The Journal of rheumatology 2002;29(3):467-73.
-
2002: Lerner Debra; Reed John I; Massarotti Elena; Wester Lisa M; Burke Thomas A
The Work Limitations Questionnaire's validity and reliability among patients with osteoarthritis.
Journal of clinical epidemiology 2002;55(2):197-208.
-
2002: McKenna F; Arguelles L; Burke T; Lefkowith J; Geis G S
Upper gastrointestinal tolerability of celecoxib compared with diclofenac in the treatment of osteoarthritis and rheumatoid arthritis.
Clinical and experimental rheumatology 2002;20(1):35-43.
-
2002: Rabeneck Linda; Wristers Kimberly; Goldstein Jay L; Eisen Glenn; Dedhiya Seema D; Burke Thomas A
Reliability, validity, and responsiveness of severity of dyspepsia assessment (SODA) in a randomized clinical trial of a COX-2-specific inhibitor and traditional NSAID therapy.
The American journal of gastroenterology 2002;97(1):32-9.
-
2001: Samet J M; Burke T A
Turning science into junk: the tobacco industry and passive smoking.
American journal of public health 2001;91(11):1742-4.
-
2001: Samet J M; Burke T A
The Bush administration, the environment and public health-warnings from the first 100 days.
International journal of epidemiology 2001;30(4):658-60.
-
2001: Zabinski R A; Burke T A; Johnson J; Lavoie F; Fitzsimon C; Tretiak R; Chancellor J V
An economic model for determining the costs and consequences of using various treatment alternatives for the management of arthritis in Canada.
PharmacoEconomics 2001;19 Suppl 1():49-58.
-
2001: Burke T A; Zabinski R A; Pettitt D; Maniadakis N; Maurath C J; Goldstein J L
A framework for evaluating the clinical consequences of initial therapy with NSAIDs, NSAIDs plus gastroprotective agents, or celecoxib in the treatment of arthritis.
PharmacoEconomics 2001;19 Suppl 1():33-47.
-
2000: Pettitt D; Goldstein J L; McGuire A; Schwartz J S; Burke T; Maniadakis N
Overview of the arthritis Cost Consequence Evaluation System (ACCES): a pharmacoeconomic model for celecoxib.
Rheumatology (Oxford, England) 2000;39 Suppl 2():33-42; discussion 57-9.
-
2000: Bensen W G; Zhao S Z; Burke T A; Zabinski R A; Makuch R W; Maurath C J; Agrawal N M; Geis G S
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
The Journal of rheumatology 2000;27(8):1876-83.
-
2000: Tran N L; Locke P A; Burke T A
Chemical and radiation environmental risk management: differences, commonalities, and challenges.
Risk analysis : an official publication of the Society for Risk Analysis 2000;20(2):163-72.
-
2000: Burke T A; Litt J S; Fox M A
Linking public health and the health of the Chesapeake Bay.
Environmental research 2000;82(2):143-9.
-
1999: Shalauta N M; Burke T A; Gordon L J; Stern B S; Tran N L
An examination of the educational needs for environmental health and protection.
Journal of public health management and practice : JPHMP 1999;5(6):1-12.
-
1997: Burke T A; Shalauta N M; Tran N L; Stern B S
The environmental Web: a national profile of the state infrastructure for environmental health and protection.
Journal of public health management and practice : JPHMP 1997;3(2):1-12.
-
1995: Burke T A; Sexton K
Integrating science and policy in a National Human Exposure Assessment Survey.
Journal of exposure analysis and environmental epidemiology 1995;5(3):283-96.
-
1992: Burke T; Anderson H; Beach N; Colome S; Drew R T; Firestone M; Hauchman F S; Miller T O; Wagener D K; Zeise L
Role of exposure databases in risk management.
Archives of environmental health 1992;47(6):421-9.
-
1992: Burke T A
Understanding environmental risk: the role of the laboratory in epidemiology, evaluation, and policy setting.
Clinical chemistry 1992;38(8B Pt 2):1519-22.
-
1992: Burke T A; Akland G
Use of gasoline exposure data and assessment. A summary report of work group III.
Journal of exposure analysis and environmental epidemiology 1992;2(1):147-50.
-
1991: Ibrahim M A; Bond G G; Burke T A; Cole P; Dost F N; Enterline P E; Gough M; Greenberg R S; Halperin W E; McConnell E
Weight of the evidence on the human carcinogenicity of 2,4-D.
Environmental health perspectives 1991;96():213-22.
-
1991: Burke T; Fagliano J; Goldoft M; Hazen R E; Iglewicz R; McKee T
Chromite ore processing residue in Hudson County, New Jersey.
Environmental health perspectives 1991;92():131-7.
-
1990: Fagliano J; Berry M; Bove F; Burke T
Drinking water contamination and the incidence of leukemia: an ecologic study.
American journal of public health 1990;80(10):1209-12.
Sign-in to see more
